CTRI/2026/07/113326进行中（未招募）2 期
A prospective study on effectiveness of individualised Homoeopathic management in cervical spondylitis evaluation through ndi and vas scale - nil
JSPS Govt Homoeo Medical College0 个研究点目标入组 30 人开始时间: 2026年7月17日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ADULTS AGED 20-70 YEARS,
- •CLINICAL DIAGNOSIS OF CERVICAL SPONDYLOSIS WITH RADIOLOGICAL CONFIRMATION
- •CHRONIC SYMPTOMS OF ATLEAST 3 MONTHS
- •PATIENT WILLING TO PARTICIPATE IN STUDY VIA SIGNED CONSENT FORM.
排除标准
- •Age above 70 years,
- •patient requiring surgical intervention,
- •severe neurological deficit,
- •red flag symptoms,
- •concurrent use OF conventional analgesics or steroids,
- •preganancy and lactation.
研究者
相似试验
进行中（未招募）
不适用
Improvement of Abnormal Vaginal Discharge in Women Using Individualized Homoeopathic TreatmentCTRI/2026/07/114139Ahmedabad Homeopathic Medical College40
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118
尚未招募
不适用
A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)Renal Insufficiency, ChronicjRCT2031260364200